medical device investing Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation
medical device investing Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation
medical device investing Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
medical device investing Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
medical device investing Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
medical device investing Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse Technology
medical device investing Pulse Biosciences Announces Clinical Data From nPulse Vybrance System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
medical device investing Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
medical device investing Pulse Biosciences' nPulse Vybrance System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
medical device investing Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
medical device investing Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
medical device investing Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
American Uranium Expands its Lo Herma ISR Uranium Project in Wyoming's Powder River Basin as Company Secures Strategically Located Uranium Mineral Rights and Stakes Additional Mining Claims
